Company Cosmo Bio Company,Limited

3386

JP3298700000

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
982 ^JPY	-0.41%		-2.48%	-0.10%

2023	Cosmo Bio Company,Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2023	Cosmo Bio Company,Limited Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Business Summary

COSMO BIO COMPANY,LIMITED is a Japan-based company mainly engaged in purchase and wholesale of research reagents, equipment, consignment services and clinical test drugs related to life science. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The Company provides clinical test drugs mainly used at hospitals and testing centers.

Number of employees: 155

Sales per Business

JPY in Million	2022	Weight	2023	Weight	Delta
Research Reagents 78.2 %	7,365	77.1 %	7,299	78.2 %	-0.90%
Equipment 21.3 %	2,086	21.8 %	1,985	21.3 %	-4.84%
Clinical Diagnostics 0.6 %	101	1.1 %	55	0.6 %	-45.54%

Sales per region

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	8,581	89.8 %	9,340	100.0 %	+8.85%

Managers

Managers	Title	Age	Since
Masanori Hayashi DFI	Director of Finance/CFO	-	-
Norihiko Shibayama PSD	President	54	00-09-30
Yasuhira Kunimoto COO	Chief Operating Officer	-	-
Junko Tochigi BRD	Director/Board Member	50	98-03-31
Ken Hasegawa PRN	Corporate Officer/Principal	-	-

Members of the board

Members of the board	Title	Age	Since
Kazuya Shimamura BRD	Director/Board Member	51	14-02-28
Norihiko Shibayama PSD	President	54	00-09-30
Junko Tochigi BRD	Director/Board Member	50	98-03-31
Haruo Sasaki BRD	Director/Board Member	-	22-03-22
Kazutoshi Sato BRD	Director/Board Member	-	-
Masanori Hayashi DFI	Director of Finance/CFO	-	-

Shareholders

Name	Equities	%	Valuation
Tokyo Small & Medium Business Invst & Consultation Co., Ltd. 19.05 %	1,152,000	19.05 %	7 M ¥
HIKARI TSUSHIN, INC. 12.12 %	733,100	12.12 %	5 M ¥
Cosmo Oil Pension Fund 9.524 %	576,000	9.524 %	4 M ¥
COSMO BIO COMPANY,LIMITED 3.515 %	212,600	3.515 %	1 M ¥
Cosmo Bio Employee Stock Ownership Plan 2.118 %	128,100	2.118 %	814 845 ¥
Yumiko Suzuki 1.361 %	82,300	1.361 %	523 511 ¥
Shoichi Matsunami 1.257 %	76,000	1.257 %	483 437 ¥
Toshiaki Funato 1.247 %	75,400	1.247 %	479 620 ¥
Cosmo Bio Restricted Stock Compensation Plan 1.189 %	71,900	1.189 %	457 357 ¥
Masanori Harada 1.141 %	69,000	1.141 %	438 910 ¥

Holdings

Name	Equities	%	Valuation
SHIN NIPPON AIR TECHNOLOGIES CO., LTD. 1.48%	360,000	1.48%	9,162,140 $
YAKULT HONSHA CO.,LTD. 0.02%	80,000	0.02%	1,568,837 $
COSMO BIO COMPANY,LIMITED 3.52%	212,600	3.52%	1,352,351 $
CAC HOLDINGS CORPORATION 0.49%	100,000	0.49%	1,256,315 $
CAC HOLDINGS CORPORATION 1.99%	100,000	1.99%	1,198,488 $
NICHIMO CO., LTD. 0.65%	58,800	0.65%	777,947 $
REPROCELL INCORPORATED 0.15%	131,900	0.15%	114,831 $